GlaxoSmithKline has been looking into claims from an anonymous tipster that its Chinese sales staff bribed doctors to prescribe drugs between 2004 and 2010, including for unauthorized uses.
Glaxosmithkline (GSK) has been looking into claims from an anonymous tipster that its Chinese